Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities
Stelis Biopharma, the biologics arm of Strides Pharma Science announced that
COVID impact report
January 2021 In 2020 the Coronavirus pandemic has, unsurprisingly, proved to
I Picked A Heck Of A Time
A new CEO’s observations on managing a fast-growing, fully integrated biophar
Stelis starts next phase of investment into its biologics manufacturing facility
This phase sees the CDMO start work on installing two 2,000-L single-use bior
Unit 1 – Bangalore, India
State-of-the-art process and analytical development facilities for small-scal
Unit 2 – Bangalore, India
Integrated state-of-the-art manufacturing facility leverages microbial and ma
Unit 3 – Bangalore, India
A multipurpose facility with an ability to cater to multiple vaccine types in
Meeting Demand for Biologics & Specialty Drugs
A company that provides insurance and investment-related products and service
Overcoming Biologic Drug Formulation Hurdles
A company that provides insurance and investment-related products and service
Stelis concludes US$ 195m Series B and Series C fund raise
Stelis Biopharma (Stelis) today announced that it has successfully concluded